Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA1084161
Max Phase: Preclinical
Molecular Formula: C31H41N5O4S2
Molecular Weight: 611.83
Molecule Type: Small molecule
Associated Items:
ID: ALA1084161
Max Phase: Preclinical
Molecular Formula: C31H41N5O4S2
Molecular Weight: 611.83
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cc1ccc2cc(C(=O)NC3(C(=O)N[C@@H](CCCN4CCN(S(N)(=O)=O)CC4)Cc4ccccc4)CCCC3)sc2c1
Standard InChI: InChI=1S/C31H41N5O4S2/c1-23-11-12-25-22-28(41-27(25)20-23)29(37)34-31(13-5-6-14-31)30(38)33-26(21-24-8-3-2-4-9-24)10-7-15-35-16-18-36(19-17-35)42(32,39)40/h2-4,8-9,11-12,20,22,26H,5-7,10,13-19,21H2,1H3,(H,33,38)(H,34,37)(H2,32,39,40)/t26-/m0/s1
Standard InChI Key: ZLJOAFCXAUKYOF-SANMLTNESA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 611.83 | Molecular Weight (Monoisotopic): 611.2600 | AlogP: 3.58 | #Rotatable Bonds: 11 |
Polar Surface Area: 124.84 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 3 |
#RO5 Violations: 1 | HBA (Lipinski): 9 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 11.42 | CX Basic pKa: 6.76 | CX LogP: 3.83 | CX LogD: 3.74 |
Aromatic Rings: 3 | Heavy Atoms: 42 | QED Weighted: 0.31 | Np Likeness Score: -1.21 |
1. Fattori D, Porcelloni M, D'Andrea P, Catalioto RM, Ettorre A, Giuliani S, Marastoni E, Mauro S, Meini S, Rossi C, Altamura M, Maggi CA.. (2010) Structure-activity relationships of 6-methyl-benzo[b]thiophene-2-carboxylic acid (1-[(S)-1-benzyl-4-[4-(tetrahydropyran-4-ylmethyl)piperazin-1-yl]butylcarbamoyl]cyclopentyl)amide, potent antagonist of the neurokinin-2 receptor., 53 (10): [PMID:20408549] [10.1021/jm100176s] |
Source(1):